Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced positive results from its Phase III study of ...

After opening its first facility in Ohio this year, biopharmaceutical processor Amgen has purchased an additional 22 acres ...

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease.

The biopharmaceutical industry faces a future full of risks and rewards. But what role will 3PL suppliers play?

Tennessee lawmakers including Sen. Marsha Blackburn should continue their staunch support for innovation and intellectual ...

As the U.S. stock market heads into the Christmas break, optimism is in the air with major indices like the Nasdaq Composite and S&P 500 posting gains, sparking hopes for a Santa Claus rally to close ...

Our Bureau, Mumbai Thursday, December 26, 2024, 16:40 Hrs [IST] ...

European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, edging 0.10% higher to 1,298.82 on the S&P Europe Select ADR Index. From continental ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...